Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 120

1.

Nox2-mediated platelet activation by glycoprotein (GP) VI: effect of rivaroxaban alone and in combination with aspirin.

Cammisotto V, Carnevale R, Nocella C, Stefanini L, Bartimoccia S, Coluccia A, Silvestri R, Pignatelli P, Pastori D, Violi F.

Biochem Pharmacol. 2019 Feb 13. pii: S0006-2952(19)30054-1. doi: 10.1016/j.bcp.2019.02.016. [Epub ahead of print]

PMID:
30771281
2.

Atrial high rate episodes in patients with cardiac implantable electronic devices: implications for clinical outcomes.

Miyazawa K, Pastori D, Li YG, Székely O, Shahid F, Boriani G, Lip GYH.

Clin Res Cardiol. 2019 Feb 13. doi: 10.1007/s00392-019-01432-y. [Epub ahead of print]

PMID:
30759274
3.

Management of Patients with Asymptomatic and Symptomatic Carotid Artery Disease: Update on Anti-Thrombotic Therapy.

Pastori D, Eikelboom JW, Anand SS, Patel MR, Tanguay JF, Ricco JB, Debus ES, Mazzolai L, Bauersachs R, Verhamme P, Bosch J, Nikol S, Nehler M, Aboyans V, Violi F.

Thromb Haemost. 2019 Jan 31. doi: 10.1055/s-0039-1678527. [Epub ahead of print]

PMID:
30703812
4.

ABC (Atrial fibrillation Better Care) pathway and healthcare costs in atrial fibrillation. The ATHERO-AF study.

Pastori D, Farcomeni A, Pignatelli P, Violi F, Lip GY.

Am J Med. 2019 Jan 16. pii: S0002-9343(19)30063-4. doi: 10.1016/j.amjmed.2019.01.003. [Epub ahead of print]

PMID:
30659810
5.

Atrial fibrillation and human immunodeficiency virus type-1 infection: a systematic review. Implications for anticoagulant and antiarrhythmic therapy.

Pastori D, Mezzaroma I, Pignatelli P, Violi F, Lip GYH.

Br J Clin Pharmacol. 2018 Dec 21. doi: 10.1111/bcp.13837. [Epub ahead of print] Review.

PMID:
30575989
6.

Digoxin and Platelet Activation in Patients With Atrial Fibrillation: In Vivo and In Vitro Study.

Pastori D, Carnevale R, Nocella C, Bartimoccia S, Novo M, Cammisotto V, Piconese S, Santulli M, Vasaturo F, Violi F, Pignatelli P; Atherosclerosis in Atrial Fibrillation (ATHERO‐AF) Study Group.

J Am Heart Assoc. 2018 Nov 20;7(22):e009509. doi: 10.1161/JAHA.118.009509.

7.

Integrated Care Management of Patients With Atrial Fibrillation and Risk of Cardiovascular Events: The ABC (Atrial fibrillation Better Care) Pathway in the ATHERO-AF Study Cohort.

Pastori D, Pignatelli P, Menichelli D, Violi F, Lip GYH.

Mayo Clin Proc. 2018 Dec 11. pii: S0025-6196(18)30891-7. doi: 10.1016/j.mayocp.2018.10.022. [Epub ahead of print]

PMID:
30551910
8.

Remnant Lipoprotein Cholesterol and Cardiovascular and Cerebrovascular Events in Patients with Non-Alcoholic Fatty Liver Disease.

Pastori D, Baratta F, Novo M, Cocomello N, Violi F, Angelico F, Del Ben M.

J Clin Med. 2018 Oct 23;7(11). pii: E378. doi: 10.3390/jcm7110378.

9.

Blood Hormones and Venous Thromboembolic Events: Lack of Association or Lack of Standardization?

Pastori D, Violi F.

Thromb Haemost. 2018 Nov;118(11):1847-1849. doi: 10.1055/s-0038-1675176. Epub 2018 Oct 12.

PMID:
30312977
10.

A Simple Clinical Risk Score (C2HEST) for Predicting Incident Atrial Fibrillation in Asian Subjects: Derivation in 471,446 Chinese Subjects, With Internal Validation and External Application in 451,199 Korean Subjects.

Li YG, Pastori D, Farcomeni A, Yang PS, Jang E, Joung B, Wang YT, Guo YT, Lip GYH.

Chest. 2018 Oct 4. pii: S0012-3692(18)32492-9. doi: 10.1016/j.chest.2018.09.011. [Epub ahead of print]

PMID:
30292759
11.

Anticoagulant therapy in patients with liver cirrhosis and portal vein thrombosis: insights for the clinician.

Basili S, Pastori D, Raparelli V, Violi F.

Therap Adv Gastroenterol. 2018 Sep 6;11:1756284818793561. doi: 10.1177/1756284818793561. eCollection 2018. Review.

12.

Corticosteroid Use and Incident Myocardial Infarction in Adults Hospitalized for Community-acquired Pneumonia.

Cangemi R, Falcone M, Taliani G, Calvieri C, Tiseo G, Romiti GF, Bertazzoni G, Farcomeni A, Violi F; SIXTUS Study Group.

Ann Am Thorac Soc. 2019 Jan;16(1):91-98. doi: 10.1513/AnnalsATS.201806-419OC.

PMID:
30188173
13.

Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study.

Raparelli V, Pastori D, Pignataro SF, Vestri AR, Pignatelli P, Cangemi R, Proietti M, Davì G, Hiatt WR, Lip GYH, Corazza GR, Perticone F, Violi F, Basili S; ARAPACIS Study Collaborators.

Intern Emerg Med. 2018 Dec;13(8):1349. doi: 10.1007/s11739-018-1922-y.

PMID:
30076553
14.

Antioxidant activity from extra virgin olive oil via inhibition of hydrogen peroxide-mediated NADPH-oxidase 2 activation.

Carnevale R, Nocella C, Cammisotto V, Bartimoccia S, Monticolo R, D'Amico A, Stefanini L, Pagano F, Pastori D, Cangemi R, Violi F.

Nutrition. 2018 Nov;55-56:36-40. doi: 10.1016/j.nut.2018.03.045. Epub 2018 Mar 29.

PMID:
29960154
15.

Left atrial thrombus resolution in non-valvular atrial fibrillation or flutter: biomarker substudy results from a prospective study with rivaroxaban (X-TRA).

Miyazawa K, Pastori D, Hammerstingl C, Cappato R, Meng IL, Kramer F, Cohen A, Schulz A, Eickels MV, Lip GYH, Marin F.

Ann Med. 2018 Sep;50(6):511-518. doi: 10.1080/07853890.2018.1495337.

PMID:
29956554
16.

Time to therapeutic range (TtTR), anticoagulation control, and cardiovascular events in vitamin K antagonists-naive patients with atrial fibrillation.

Pastori D, Pignatelli P, Cribari F, Carnevale R, Saliola M, Violi F, Lip GY.

Am Heart J. 2018 Jun;200:32-36. doi: 10.1016/j.ahj.2018.03.004. Epub 2018 Mar 10.

PMID:
29898846
17.

Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants.

Pastori D, Lip GYH, Farcomeni A, Del Sole F, Sciacqua A, Perticone F, Marcucci R, Grifoni E, Pignatelli P, Violi F; ATHERO-AF study group.

Int J Cardiol. 2018 Aug 1;264:58-63. doi: 10.1016/j.ijcard.2018.01.097.

PMID:
29776574
18.

Gut-derived lipopolysaccharides increase post-prandial oxidative stress via Nox2 activation in patients with impaired fasting glucose tolerance: effect of extra-virgin olive oil.

Carnevale R, Pastori D, Nocella C, Cammisotto V, Bartimoccia S, Novo M, Del Ben M, Farcomeni A, Angelico F, Violi F.

Eur J Nutr. 2018 May 16. doi: 10.1007/s00394-018-1718-x. [Epub ahead of print]

PMID:
29766292
19.

Blood hydrogen peroxide break-down activity in healthy subjects and in patients at risk of cardiovascular events.

Carnevale R, Nocella C, Pignatelli P, Bartimoccia S, Stefanini L, Basili S, Novo M, D'Amico A, Cammisotto V, Pastori D, Violi F.

Atherosclerosis. 2018 Jul;274:29-34. doi: 10.1016/j.atherosclerosis.2018.04.025. Epub 2018 Apr 25.

PMID:
29747088
20.

Prognostic and therapeutic implications of vascular disease in patients with atrial fibrillation.

Shahid F, Pastori D, Violi F, Lip GYH.

Pharmacol Res. 2018 Jun;132:149-159. doi: 10.1016/j.phrs.2018.04.019. Epub 2018 Apr 23. Review.

PMID:
29698794

Supplemental Content

Loading ...
Support Center